Apyx Medical
(NASDAQ) APYX
Apyx Medical Financials at a Glance
Market Cap
$154.35M
Revenue (TTM)
$52.84M
Net Income (TTM)
$11.21M
EPS (TTM)
$-0.27
P/E Ratio
-13.46
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.71
Volume
1,056
Open
$3.77
Price
$3.71
Volume
1,056
Open
$3.77
Previous Close
$3.71
Daily Range
$3.69 - $3.84
52-Week Range
$0.76 - $4.50
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.71
Volume
1,056
Open
$3.77
Previous Close
$3.71
Daily Range
$3.69 - $3.84
52-Week Range
$0.76 - $4.50
APYX News
APYX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Apyx Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
205
CEO
Charles D. Goodwin, II
Website
apyxmedical.comHeadquarters
Clearwater, FL 33760, US
APYX Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
-12%
Net Income Margin
-21%
Return on Equity
-78%
Return on Capital
-12%
Return on Assets
-17%
Earnings Yield
-7.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$154.35M
Shares Outstanding
41.83M
Volume
1.06K
Short Interest
0.00%
Avg. Volume
134.45K
Financials (TTM)
Gross Profit
$19.03M
Operating Income
$6.45M
EBITDA
$5.79M
Operating Cash Flow
$8.00M
Capital Expenditure
$1.11M
Free Cash Flow
$9.12M
Cash & ST Invst.
$31.74M
Total Debt
$39.34M
Apyx Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.16M
+34.7%
Gross Profit
$2.01M
-122.4%
Gross Margin
-10.50%
N/A
Market Cap
$154.35M
N/A
Market Cap/Employee
$701.59K
N/A
Employees
220
N/A
Net Income
$1.30M
+71.9%
EBITDA
$232.00K
+108.4%
Quarterly Fundamentals
Net Cash
$7.60M
-8.2%
Accounts Receivable
$16.78M
+8.4%
Inventory
$8.60M
+13.7%
Long Term Debt
$38.91M
+1.3%
Short Term Debt
$428.00K
+20.6%
Return on Assets
-16.77%
N/A
Return on Invested Capital
-11.69%
N/A
Free Cash Flow
$2.81M
+11.8%
Operating Cash Flow
$2.53M
+13.9%